Search Within

Glenn Heller

Formats
  1. Journal Article (268)
  2. Meeting Abstract (123)
  3. Conference Paper (9)
Groups
  1. Biostatistics Service (400)
  2. Epidemiology and Biostatistics (400)
  3. Department of Medicine (300)
  4. GSK Faculty (193)
  5. Center for Hematologic Malignancies (162)
  6. Pediatrics, Department of (158)

More Groups

People
  1. Howard Scher (89)
  2. Richard O'Reilly (75)
  3. Nancy Kernan (59)
  4. Michael Morris (54)
  5. James Young (52)
  6. Marcel Van Den Brink (47)

More People

Years
  1. 2025 (4)
  2. 2024 (6)
  3. 2023 (9)
  4. 2022 (9)
  5. 2021 (9)
  6. 2020 (12)

More Years

Publications
  1. Journal of Clinical Oncology (82)
  2. Blood (69)
  3. Biology of Blood and Marrow Transplantation (32)
  4. Clinical Cancer Research (24)
  5. Bone Marrow Transplantation (13)
  6. Cancer (13)

More Publications

Publishers
  1. American Society of Clinical Oncology (84)
  2. American Society of Hematology (70)
  3. Elsevier Inc. (41)
  4. American Association for Cancer Research (40)
  5. Nature Publishing Group (26)
  6. Elsevier Science, Inc. (24)

More Publishers

Results (400)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • High-resolution DNA typing for HLA-A, -B, and -DRB1 has direct impact on the survival in the recipients of unrelated donor (URD) hematopoietic stem cell transplant (HSCT)
    Meeting Abstract

    Prasad, V.; Kernan, N. A.; Heller, G.; Boulad, F.; Castro-Malaspina, H.; Jakubowski, A.; Papadopoulos, E.; Perales, M.; Small, T. N.; Van Den Brink, M.; more...
    Blood (2002)

    Fulltext@MSK | Save
  • Quantifying the amount of variation in survival explained by prostate-specific antigen
    Journal Article

    Verbel, D. A.; Heller, G.; Kelly, W. K.; Scher, H. I.
    Clinical Cancer Research (2002)

    Fulltext@MSK | Save
  • 17-Allylamino-17-demethoxygeldanamycin induces the degradation of androgen receptor and HER-2/neu and inhibits the growth of prostate cancer xenografts
    Journal Article

    Solit, D. B.; Zheng, F. F.; Drobnjak, M.; Münster, P. N.; Higgins, B.; Verbel, D.; Heller, G.; Tong, W.; Cordon-Cardo, C.; Agus, D. B.; more...
    Clinical Cancer Research (2002)

    Fulltext@MSK | Save
  • Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: A report from the Childhood Cancer Survivor Study
    Journal Article

    Sklar, C. A.; Mertens, A. C.; Mitby, P.; Occhiogrosso, G.; Qin, J.; Heller, G.; Yasui, Y.; Robison, L. L.
    Journal of Clinical Endocrinology and Metabolism (2002)

    Fulltext@MSK | Save
  • Picking the winners in a sea of plenty
    Journal Article

    Scher, H. I.; Heller, G.
    Clinical Cancer Research (2002)

    Fulltext@MSK | Save
  • Direct evidence for new T-cell generation by patients after either T-cell-depleted or unmodified allogeneic hematopoietic stem cell transplantations
    Journal Article

    Lewin, S. R.; Heller, G.; Zhang, L.; Rodrigues, E.; Skulsky, E.; van den Brink, M. R. M.; Small, T. N.; Kernan, N. A.; O'Reilly, R. J.; Ho, D. D.; more...
    Blood (2002)

    Fulltext@MSK | Save
  • Quantitation, selection, and functional characterization of Epstein-Barr virus-specific and alloreactive T cells detected by intracellular interferon-γ production and growth of cytotoxic precursors
    Journal Article

    Koehne, G.; Smith, K. M.; Ferguson, T. L.; Williams, R. Y.; Heller, G.; Pamer, E. G.; Dupont, B.; O'Reilly, R. J.
    Blood (2002)

    Fulltext@MSK | Save
  • Financial analysis of patients with newly diagnosed acute myelogenous leukemia on protocol or standard therapy
    Journal Article

    Berman, E.; Little, C.; Teschendorf, B.; Jones, M.; Heller, G.
    Cancer (2002)

    Fulltext@MSK | Save
  • N7: A novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age
    Journal Article

    Cheung, N. K. V.; Kushner, B. H.; Laquaglia, M.; Kramer, K.; Gollamudi, S.; Heller, G.; Gerald, W.; Yeh, S.; Finn, R.; Larson, S. M.; more...
    Medical and Pediatric Oncology (2001)

    Fulltext@MSK | Save
  • Human epidermal growth factor receptor 2 as a prognostic indicator in osteogenic sarcoma
    Journal Article

    Morris, C. D.; Gorlick, R.; Huvos, A. G.; Heller, G.; Meyers, P. A.; Healey, J. H.
    Clinical Orthopaedics and Related Research (2001)

    Fulltext@MSK | Save